H&HN is an AHA Publication
A new approach to treating inflammatory diseases could revolutionize care , says Christopher Czura, VP of scientific affairs at the Feinstein Institute for Medical Research.
In health care, we are near the end of the first act of whatever you want to call this vast change we are going through.